Pelthos Therapeutics (PTHS) Cash from Financing Activities (2023 - 2026)
Pelthos Therapeutics (PTHS) reported Cash from Financing Activities of $27.52 million for Q1 2026, compared with $250,000 a year earlier and up 52.7% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Cash from Financing Activities (2023 - 2026) Analysis & Trends
For FY2025, Pelthos Therapeutics posted Cash from Financing Activities of $45.34 million, up 630.2% from FY2024.
- Cash from Financing Activities has a three-year compound annual growth rate of 203.5% (FY2022 to FY2025).
- By year, Cash from Financing Activities came in at $6.21 million in FY2024 (+507.3%), $1.02 million in FY2023 (-37.0%) and $1.62 million in FY2022.
- The Q1 2026 figure ranks as the highest quarterly Cash from Financing Activities in data going back to Q1 2023.
- Per Business Quant data, the three quarters before Q1 2026 came in at $18.02 million (Q4 2025), $26.69 million (Q3 2025) and $375,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Pelthos Therapeutics | 79.95 Mn | -8.44 Mn | 11.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 27.52 Mn |
| Dec 31, 2025 | 18.02 Mn |
| Sep 30, 2025 | 26.69 Mn |
| Jun 30, 2025 | 375,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | -972,015.00 |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 5.67 Mn |
| Dec 31, 2023 | 430,412.00 |
| Sep 30, 2023 | 198,128.00 |
| Jun 30, 2023 | 226,905.00 |
| Mar 31, 2023 | 166,903.00 |
API Access
Pelthos Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();